Categories
Archives
Recommended Sites
- Affordable Web Hosting
- Bed Bug Registry
- Bing Search
- Conscious Evolution
- Cryomedical Blog
- Free Health Insurance Quote
- Free Loan Quote
- Genistein Net
- Google Search
- HGH
- HGH Injections
- HGH Prescription
- HGH Side Effects
- HGH Therapy
- Hormone Therapy
- Injectable Testosterone
- Medical School Review
- New York City Real Estate
- Palm Beach Real Estate
- SEO Web Design
- Start Your Own Internet Services Company
- Testosterone Injections
- Testosterone Replacement Therapy
- WholeSale Domain Names
- Yahoo Search
Category Archives: Cell Medicine
Advanced Cell Technology Announces Approval of Wills Eye Institute as Additional Site for Stem Cell Clinical Trial for …
MARLBOROUGH, Mass.–(BUSINESS WIRE)– Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that the Wills Eye Institute in Philadelphia has received institutional review board (IRB) approval as a site for the company’s Phase I/II clinical trial for Stargardt’s Macular Dystrophy (SMD), a form of juvenile macular degeneration, using human embryonic stem cell (hESC)-derived retinal pigment epithelial (RPE) cells. Continue reading
Posted in Cell Medicine
Tagged circumstances, emergency, information, light, statements, survey, time, words
Comments Off
Stem cells – ISWA project – Video
14-02-2012 08:13 STEM CELLS The dance of life Recent developments in regenerative medicine and modern biology are going to have an enormous impact on our lives. Also the way itself we face the problem of sickness, aging and death changes as the hope (or the illusion?) grows that we always can fight and delay them Continue reading
Posted in Cell Medicine
Tagged a-and-very, a-cornea-and, a-damaged-one, a-new-tissue, changes-as-the, culture, etherogeneus, impact-on-our, innovative-, japanese, knowledge, stem, university-team
Comments Off
Bioheart Acquires Exclusive Rights to Ageless Regenerative Institute's Adipose Cell Technology
SUNRISE, Fla., Feb. 14, 2012 (GLOBE NEWSWIRE) — Bioheart, Inc. Continue reading
Posted in Cell Medicine
Tagged cardiovascular, collaboration, forward-looking, institute, management, president, report-on-form, securities, standardization, therapeutic
Comments Off
Dr. Ramaswamy on Dormant Tumor Cells and Resistance – Video
13-02-2012 12:31 Sridhar Ramaswamy, MD, Tucker Gosnell Investigator and Associate Professor of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Broad Institute of Harvard and MIT, and Harvard Stem Cell Institute, discusses ongoing research into drug tolerance and resistance, specifically the roll of dormant cancer cells. Continue reading
Posted in Cell Medicine
Tagged a-drug-holiday-, additive-effect, and-resistance, broad-institute, drug-tolerance, exact-mechanism, harvard, harvard-medical, harvard-stem, massachusetts, medicine--, research, school, tucker-gosnell
Comments Off
Third patient dosed in Phase 1/2 SMD trial using RPE cells derived from hESCs
Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today the dosing of third patient in its Phase 1/2 trial for Stargardt's macular dystrophy (SMD) using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs). Continue reading
Posted in Cell Medicine
Tagged clinical, david-geffen, first, medicine--, ophthalmology, patient, patients-under, stargardt, steven-schwartz, technology, third, treatment, university
Comments Off
ACT Announces Third Patient with Stargardt’s Disease Treated in U.S. Clinical Trial with RPE Cells Derived from …
MARLBOROUGH, Mass.–(BUSINESS WIRE)– Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today the dosing of third patient in its Phase 1/2 trial for Stargardt’s macular dystrophy (SMD) using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs) Continue reading
Posted in Cell Medicine
Tagged advanced-cell, california, circumstances, data, information, medicine--, news, ophthalmology, safety, school, technology, united-states, university
Comments Off
Cytomedix Expands Commitment to Regenerative Medicine With Acquisition of Aldagen
GAITHERSBURG, MD–(Marketwire -02/08/12)- Cytomedix, Inc. (OTC.BB: CMXI.OB – News) (the “Company”), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, announces the completion of the acquisition of Aldagen, Inc., a privately-held biopharmaceutical company developing regenerative cell therapies based on its proprietary ALDH bright cell (“ALDHbr”) technology. Under the terms of the transaction as described below, Cytomedix issued preferred shares valued at $16 million based on a 10-day volume-weighted average price (“VWAP”) calculated through February 2, 2012 Continue reading
Posted in Cell Medicine
Tagged acquisition, aldagen, board, chairman, conference, cytomedix, europe, internet, press, safety, securities, transaction, treatment
Comments Off
Meet the Founders of Cord Blood Registry – Video
01-02-2012 13:37 Meet founders of Cord Blood Registry, Tom and Wendy. Hear why they started CBR — a family business dedicated to helping people live healthier lives through cord blood stem cell medicine Continue reading
Posted in Cell Medicine
Tagged applicable-for, blood-registry-, clinical-trials, condition, family, family-business, future, helping-leading, laboratory, matched-sibling, privacy-policy, suitable-donor
Comments Off
Insights Into MI6: Big Pharma – Video
01-02-2012 21:36 Notes from the interview: Nicholas Anderson – Author, NOC: British Secret Operations Big Pharma… must be careful in discussing reason for writing books is in part because of something along these lines medical doctor helped to exfiltrate from soviet union end of 1991 doctor wanted to meet.. Continue reading
Posted in Cell Medicine
Tagged a-prevented-him, book, british-secret, couple-examples, fiction, interview, media, medicine--
Comments Off